A Memphis startup should not receive the same investor list whether it makes a medical device, farm technology or business software. The local specialists have real sector boundaries, and Tennessee’s wider capital routes enter at different stages. This guide turns those distinctions into a shortlist founders can use before asking for an introduction.
Compare 16 investment routes by connection, stage and sector, then use the worked example and copyable worksheet to build a more useful first research wave.
Choose the Memphis shortlist by product and stage
| Your situation | Research first | Prepare or clarify |
|---|---|---|
| Medical-device development | MB Venture Partners; Solas and stage-matched healthcare specialists | Show the clinical problem, development evidence and next milestone. |
| AgTech or FarmTech | Innova; other relevant agriculture specialists | Use Innova’s current new-investment thesis, not its legacy portfolio. |
| Software or healthcare business with revenue | InvestTN, Market Square, NCN, Capacity; later-stage specialists where ready | Separate seed validation from early commercial growth. |
Pick a small first wave you can research well. For every candidate, save one source-backed reason for fit and one question to resolve. Prioritize the firms that fit the company you have today, not the stage you hope to reach next year.
Compare 16 investor routes
This is an unranked, selective list of investment organizations and clearly identified investor networks. The connection column is a navigation aid, not a claim that every firm has a city office or accepts every local company. On small screens, scroll the table sideways to compare all columns.
| Investor or network | Connection | Initial-stage distinction | Company focus |
|---|---|---|---|
| MB Venture Partners | Local connection: Memphis; specialist wider opportunities | Medical-device development stages | Life sciences, especially medical devices |
| Innova | Local connection: Memphis-based; agriculture technology | First institutional and early stage | AgTech and FarmTech for new capital |
| InvestTN / Launch Tennessee | State / regional: Tennessee-located startups | Early stage; direct-company strategy | Tennessee startup innovation |
| Nashville Capital Network | State / regional: Tennessee-based; wider qualifying companies | Early growth | Healthcare and technology |
| Martin Ventures | State / regional: Nashville-based; wider healthcare businesses | Healthcare company building and venture stages | Healthcare delivery and technology |
| FINTOP Capital | State / regional: Tennessee-based; financial-services network | Venture stage; confirm entry round | Financial technology |
| Frist Cressey Ventures | State / regional: Nashville-based; wider U.S. healthcare | Venture stage; confirm strategy | Healthcare |
| Relevance Ventures | State / regional: Tennessee-based; wider eligible companies | Early growth, Series A–C | Digital, personal, community and financial health |
| Claritas Capital | State / regional: Nashville-based; wider qualifying companies | Established business model; venture and growth | Healthcare, technology and media/entertainment |
| Market Square Ventures | State / regional: Knoxville, Tennessee, Southeast and Appalachia | Early stage | Multiple startup sectors |
| Solas BioVentures | State / regional: Chattanooga-linked; worldwide reach | Early stage | Biopharmaceuticals, medical devices and digital health |
| Capacity Capital | State / regional: Bias toward Southeast U.S. | Early commercial stage with sustained revenue | Capital-efficient high-growth companies |
| Render Capital | State / regional: Louisville, Southern Indiana and Middle America corridor | Pre-seed and seed | Legacy-industry technology and commerce |
| Overline | Wider mandate: Atlanta and Southeast | Inception through seed | Early high-growth companies |
| Valor Ventures | Wider mandate: Southern U.S. | First institutional rounds | B2B software |
| Tech Square Ventures | Wider mandate: Atlanta-linked; wider enterprise opportunities | Primarily seed; selected pre-seed and Series A | Enterprise and marketplace technology |
Is Innova still a general Memphis technology investor?
Its current website says new capital goes exclusively into AgTech and FarmTech, while it continues supporting its legacy portfolio. That means an older healthcare or general-technology investment is not evidence of today’s intake. A founder with an agriculture product should use the current pitch route; a founder outside that thesis should choose a better-matched entry below.
How can Memphis healthcare founders choose the right specialist?
Start with the kind of company and its evidence. MB Venture Partners primarily targets medical devices, particularly musculoskeletal opportunities. Solas spans several life-science categories. Martin and Frist Cressey focus on healthcare company building and outcomes, while Relevance currently names Series A–C. Match the company to the mechanism and stage instead of treating healthcare as one financing category.
16 investors and networks to research
1. MB Venture Partners
Venture capital firm. MB Venture Partners is Memphis-based and primarily invests in medical-device startups, with particular interest in musculoskeletal disease. A device founder should lead with the clinical problem and development milestone. General health software should not assume the same thesis applies.
Public approach: Use the official contact page. Official MB Venture Partners information.
2. Innova
Venture capital firm. Innova’s current new-capital mandate is exclusively AgTech and FarmTech. It still supports a broader legacy portfolio, but those older companies do not define today’s intake. An agriculture founder should explain the farm problem, technology and path to practical adoption.
Public approach: Use the official Pitch Us route. Official Innova information.
3. InvestTN / Launch Tennessee
Public venture-investment program. InvestTN makes equity investments into Tennessee-located startups as well as venture funds. Use the direct-company route for founder research and keep fund allocations separate. It is one investment program, not an extra investor for every Launch Tennessee support initiative.
Public approach: Follow the official InvestTN website and founder application. Official InvestTN / Launch Tennessee information.
4. Nashville Capital Network
Investment network and funds. Nashville Capital Network combines investment capital with an experienced investor community. Its current positioning is acceleration capital for early-growth businesses. For a company with customer evidence, the useful question is which operating relationships and financing milestone the partnership would support.
Public approach: Use the official approach and contact route. Official Nashville Capital Network information.
5. Martin Ventures
Venture capital firm. Martin Ventures builds and backs healthcare companies, with a strong emphasis on how care is delivered and paid for. A founder should explain the patient, provider and economic problem together. This is a healthcare-company-building route, not a sector-agnostic startup fund.
Public approach: Use the official Connect information. Official Martin Ventures information.
6. FINTOP Capital
Venture capital firm. FINTOP brings founder and operator experience together with a financial-services network. It is particularly useful to research when banks or other financial institutions are buyers, channels or partners. Explain the institution’s workflow and adoption case, rather than presenting fintech as one undifferentiated market.
Public approach: Use the official Connect page. Official FINTOP Capital information.
7. Frist Cressey Ventures
Venture capital firm. Frist Cressey Ventures backs companies working to improve healthcare and patient outcomes. Its value proposition extends into strategic industry relationships. Show where your company fits in care delivery, purchasing and implementation, and establish the current entry-stage fit with the team.
Public approach: Use the official strategy and contact information. Official Frist Cressey Ventures information.
8. Relevance Ventures
Venture capital firm. Relevance currently emphasizes prevention and holistic health, investing at Series A through C. That stage distinction matters for a company still seeking its first outside check. A commercially established team should connect its product to one of the firm’s defined health categories.
Public approach: Use the official strategy and contact page. Official Relevance Ventures information.
9. Claritas Capital
Venture capital firm. Claritas separates venture capital from real estate and describes debt or equity for businesses with an established model. Show commercial progress and the specific kind of capital required. Its presence in a venture directory should not be read as an idea-stage financing commitment.
Public approach: Use the official Venture Capital and contact pages. Official Claritas Capital information.
10. Market Square Ventures
Venture capital firm. Market Square Ventures is based in Knoxville and explicitly focuses on early startups across Tennessee, the Southeast and Appalachia. This makes it a relevant regional path beyond one city. Prepare the customer insight, development evidence and specific next milestone.
Public approach: Use the pitch-deck email published on the official site. Official Market Square Ventures information.
11. Solas BioVentures
Venture capital firm. Solas is an early-stage life-sciences investor with worldwide reach. Its focus spans biopharmaceuticals, devices and digital health, so the right evidence depends on the product. Explain the development and commercialization risks the proposed round will reduce.
Public approach: Use the official team information and published contact details. Official Solas BioVentures information.
12. Capacity Capital
Venture capital firm. Capacity looks for cash-efficient growth, sustained revenue and a line of sight to break-even. Its published fit is different from long-cycle R&D or winner-take-all spending. Explain the business inflection and why risk capital is the appropriate tool.
Public approach: Use the official Apply for Funding route. Official Capacity Capital information.
13. Render Capital
Venture capital firm. Render invests early in companies across a Middle America industry corridor. Its current thesis is not sector-unlimited: read the exclusions as well as the focus areas. Present the customer, industry change and use of first institutional capital.
Public approach: Use Submit Your Deck on the official site. Official Render Capital information.
14. Overline
Venture capital firm. Overline explicitly invests from inception through seed across the Southeast. That makes it a plausible early institutional lane before a founder has a polished growth story. Be precise about the problem, what has been learned and the next evidence-building milestone.
Public approach: Use the official Share Your Pitch page. Official Overline information.
15. Valor Ventures
Venture capital firm. Valor leads first rounds in B2B software across the South. This is a more precise match than a generic regional VC description. Show a real business customer, a compelling workflow and why your team has an advantage in serving the market.
Public approach: Use Share a Startup With Valor on the official site. Official Valor Ventures information.
16. Tech Square Ventures
Venture capital firm. Tech Square invests in enterprise and marketplace technology, primarily at seed. Its current approach can be relevant to companies selling into established businesses. Explain adoption, buyer incentives and the evidence behind a repeatable commercial opportunity.
Public approach: Use the official stage/focus and contact pages. Official Tech Square Ventures information.
A Memphis agriculture startup separates its local and software routes
Fictional worked example. A fictional farm-operations company has tested a sensor-and-software product with growers. The proposed round would fund a second deployment season and a more reliable product. The team has field evidence but little recurring revenue.
| Candidate lane | Next action | Why it changes the decision |
|---|---|---|
| Innova | Explain the farm problem and technology adoption evidence | The current agriculture thesis creates a specific local fit. |
| InvestTN / Market Square | Check Tennessee and early-stage criteria | These are different geographic and stage routes. |
| Capacity / Relevance | Defer unless the published commercial or sector conditions match | A cash-efficient revenue screen and a later health thesis may not fit this round. |
Keep the round tied to a concrete milestone. The round-size planning worksheet can help organize assumptions before you commit to an outreach target.
Build your Memphis, Tennessee investor-fit worksheet
Use one card per investment organization and strategy. The worksheet works in a document, spreadsheet or Finta research notes. Keep verified facts, assumptions and unanswered questions distinct.
INVESTOR FIT CARD: MEMPHIS, TENNESSEE
Company and next funding milestone: [authorized company facts]
Product category: [device / agriculture / software / healthcare delivery]
Field or clinical evidence: [what exists; what remains to prove]
Funding milestone: [development / repeat deployment / commercial growth]
Investor family and specific vehicle: [current name; avoid duplicates]
Official stage, sector and geography: [source URL and research date]
Fit evidence: [what actually matches]
Mismatch or open question: [what remains unresolved]
Investor role: [lead / participant / unknown; source or direct confirmation]
Approach route: [public founder route / team contact / permitted introduction]
Relationship context: [known person; permission to ask; no assumed introduction]
Owner, next action and follow-up date: [person; task; date]Bring your shortlist into Finta to connect investor research, relationship context, conversations and follow-up. Aurora can help organize the context and prepare next steps for your review. You stay in control of the approach and the information shared.
Review the shortlist with Aurora, Claude or Codex
Use the public sources and company information you are authorized to share. Check the output against those sources before acting.
Help me build an evidence-backed investor shortlist for a Memphis, Tennessee startup.
Company, location, current evidence and next funding milestone: [authorized facts]
Candidates and official sources: [names, URLs and dates]
Separate local offices, regional requirements and wider investment eligibility.
Check the current investor family, vehicle, entry stage, sector and public founder route.
Distinguish equity investors, angel networks, investing accelerators, grants and service providers.
Do not infer current eligibility from a historic portfolio investment or a nearby office.
Return a table: investor, fit evidence, mismatch, unknown, next question and action owner.
Choose a small first research wave and explain exclusions.
Keep missing or contradictory facts as unknown rather than inventing answers.
Do not contact anyone, submit applications or share confidential information.Keep the broader raise connected with the pre-seed guide, Seed Fundraising Comprehensive Guide and investor-prospecting workflow. For a national starting point, see the U.S. venture-capital and angel-investor guide.
Methodology and research date
By Finta Editorial Team. Official investor and institutional materials reviewed November 13, 2026. This guide includes 16 investor families or clearly identified networks: 2 local connections, 11 state or regional routes and 3 wider options. A local connection can be a university route or regional network group, not necessarily a standalone fund office.
Names, investment roles and published theses were checked against the official sources linked in each profile. Related managers, rebrands and chapters are grouped conservatively. Unspecified entry stages, geography and current intake are left as questions, not invented criteria. A published strategy is not a guarantee of available capital or a funding outcome. The cover is an editorial ecosystem illustration, not a map of investor offices or actual financing flows.
Not counted or kept separate:
- Innova’s old healthcare and general-technology portfolio is not treated as its current new-capital mandate.
- Startup support programs and matching grants are not counted as equity investors.
General information, not personalized financial, legal or tax advice. Confirm investment terms and company eligibility with the provider and appropriate advisers.